REVIVE: Replens Versus Intra-Vaginal Estrogen for the Treatment of Vaginal Dryness on Aromatase Inhibitor Therapy
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Estrogen Receptor Positive Breast Cancer|Breast Cancer
Interventions: DRUG: ESTRING|DRUG: Replens
Sponsor: Polly A. Niravath, MD